CAG
BSX icon

Csenge Advisory Group’s Boston Scientific BSX Stock Holding History

Csenge Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,101
Closed -$221K – 694
2025
Q2 		$221K Sell
2,101
-646
-24% -$65.4K 0.01% 637
2025
Q1 		$261K Sell
2,747
-322
-10% -$32.4K 0.01% 567
2024
Q4 		$274K Sell
3,069
-1,238
-29% -$109K 0.01% 573
2024
Q3 		$375K Buy
4,307
+435
+11% +$34.3K 0.02% 497
2024
Q2 		$298K Buy
3,872
+278
+8% +$20.3K 0.02% 525
2024
Q1 		$246K Buy
+3,594
New +$231K 0.01% 606
2018
Q4 		– Sell
-188
Closed -$6K – 371
2018
Q3 		$6K Buy
+188
New +$6.57K ﹤0.01% 581

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Csenge Advisory Group's BSX Position: Q3 2025 in Review

Csenge Advisory Group sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,101 shares — an estimated $221K sold.

Csenge Advisory Group first reported a position in BSX in Q3 2018 and held it in 7 quarters. The position peaked at $375K in Q3 2024. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Csenge Advisory Group reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • Csenge Advisory Group sold 2,101 Boston Scientific shares in Q3 2025, an estimated $221K.
  • Csenge Advisory Group first reported a position in Boston Scientific in Q3 2018 and held it in 7 quarters.
  • Csenge Advisory Group's Boston Scientific position peaked at $375K in Q3 2024.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Csenge Advisory Group's 13F filing for Q3 2025, filed 28 Oct 2025.